Why industry leaders are choosing the Simoa® technology for Phase I – IV Clinical Studies 

Event Date

LISTEN ON DEMAND

 

 

Join Dr. Maribeth Raines, Vice President of Laboratory Services at Pacific Biomarkers and Kevin Hrusovsky, CEO and Chairman of Quanterix as they discuss how the next generation Simoa SP-X™ Imaging and Analysis System and CorPlex™ Assays are helping accelerate clinical trials and drug development programs. . Dr Raines will share specific examples of how these single- and multiplex assays provide CROs like Pacific Biomarkers with the resources to support Phase I-IV clinical trials more effectively.

Learning Objectives at this Complimentary Webinar:

  • Understand how top CRO labs are utilizing the Simoa SP-X Imaging and Analysis System
  • Highlight select Simoa assays (single and multiplex) and how they benefit clinical trials
  • Understand the role of novel biomarker detection technologies in clinical trial endpoint considerations
  • Learn about specific examples of utilizing novel biomarker detection technologies to advance the understanding of drug efficacy, toxicity, dosage response, and other parameters